Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,232
datasets available to search
ShareScore release 0.9.0
Dataset results
2,232 results for “Cancer cell lines”
Nivolumab in Combination With Ipilimumab (Part 1); Nivolumab Plus Ipilimumab in Combination With Chemotherapy (Part 2) as First Line Therapy in Stage IV Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT02659059. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Vaccine Therapy in Patients With Stages IIIB/IV Non-Small Cell Lung Cancer Who Have Finished First-Line Chemotherapy
ClinicalTrials.gov study NCT00534209. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study of Carboplatin-Paclitaxel/Nab-Paclitaxel Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With First Line Metastatic Squamous Non-small Cell Lung Cancer (MK-3475-407/KEYNOTE-407)
ClinicalTrials.gov study NCT03875092. IPD Sharing: YES. Countries: 1. Publications: 2.
First-line Treatment of Participants With Stage IV Squamous Non-Small Cell Lung Cancer With Necitumumab and Gemcitabine-Cisplatin
ClinicalTrials.gov study NCT00981058. IPD Sharing: Not stated. Countries: 26. Publications: 4.
Cilengitide and Cetuximab in Combination With Platinum-based Chemotherapy as First-line Treatment for Subjects With Advanced Non Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT00842712. IPD Sharing: Not stated. Countries: 8. Publications: 1.
Study of Durvalumab With Tremelimumab Versus SoC as 1st Line Therapy in Metastatic Non Small-Cell Lung Cancer (NSCLC) (NEPTUNE)
ClinicalTrials.gov study NCT02542293. IPD Sharing: YES. Countries: 29. Publications: 1.
Sunitinib Malate Schedule 4/2 vs. Sunitinib Malate Continuous Dosing As First-Line Therapy For Metastatic Renal Cell Cancer (RCC)
ClinicalTrials.gov study NCT00267748. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Study of Pegilodecakin (LY3500518) With Pembrolizumab Compared to Pembrolizumab Alone First-line Tx in Participants With Metastatic Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT03382899. IPD Sharing: YES. Countries: 1. Publications: 1.
An Open-Label, Randomized, Phase 3 Trial of Nivolumab Versus Investigator's Choice Chemotherapy as First-Line Therapy for Stage IV or Recurrent PD-L1+ Non-Small Cell Lung Cancer (CheckMate 026)
ClinicalTrials.gov study NCT02041533. IPD Sharing: Not stated. Countries: 26. Publications: 2.
Real World Utilization and Outcomes With Dacomitinib First Line Treatment for EGFR Mutation-positive Advanced Non Small Cell Lung Cancer Among Asian Patients - A Multi Center Chart Review
ClinicalTrials.gov study NCT04609319. IPD Sharing: NO. Countries: 3. Publications: 1.
A Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First- Line Platinum-Based Chemotherapy in Participants With Extensive Stage Small Cell Lung Cancer (MERU)
ClinicalTrials.gov study NCT03033511. IPD Sharing: YES. Countries: 41. Publications: 1.
A Study of Chemotherapy and Ramucirumab Versus Chemotherapy Alone in Second Line Non-Small Cell Lung Cancer (NSCLC) Participants Who Received Prior First Line Platinum-based Chemotherapy
ClinicalTrials.gov study NCT01168973. IPD Sharing: YES. Countries: 27. Publications: 4.
Erlotinib and Docetaxel in Second Line of Treatment in Patients With Non Small Cell Lung Cancer
ClinicalTrials.gov study NCT01350817. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Pembrolizumab With Maintenance Olaparib or Maintenance Pemetrexed in First-line (1L) Metastatic Nonsquamous Non-Small-Cell Lung Cancer (NSCLC) (MK-7339-006, KEYLYNK-006)
ClinicalTrials.gov study NCT03976323. IPD Sharing: YES. Countries: 20. Publications: 1.
LUME-Lung 1: BIBF 1120 Plus Docetaxel as Compared to Placebo Plus Docetaxel in 2nd Line Non Small Cell Lung Cancer
ClinicalTrials.gov study NCT00805194. IPD Sharing: Not stated. Countries: 27. Publications: 2.
A Study of ASP8273 vs. Erlotinib or Gefitinib in First-line Treatment of Patients With Stage IIIB/IV Non-small Cell Lung Cancer Tumors With EGFR Activating Mutations
ClinicalTrials.gov study NCT02588261. IPD Sharing: YES. Countries: 23. Publications: 1.
Study of Cisplatin/Vinorelbine +/- Cetuximab as First-line Treatment of Advanced Non Small Cell Lung Cancer (FLEX)
ClinicalTrials.gov study NCT00148798. IPD Sharing: Not stated. Countries: 28. Publications: 5.
To Compare Efficacy and Safety of CT-P16 and European Union-Approved Avastin as First-Line Treatment for Metastatic or Recurrent Non-Squamous Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT03676192. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study of Tarceva (Erlotinib) or Placebo in Combination With Platinum-Based Therapy as First Line Treatment in Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00883779. IPD Sharing: Not stated. Countries: 7. Publications: 1.
A Study of Aflibercept Versus Placebo in Patients With Second-Line Docetaxel for Locally Advanced or Metastatic Non-Small-Cell Lung Cancer
ClinicalTrials.gov study NCT00532155. IPD Sharing: Not stated. Countries: 32. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.